全文获取类型
收费全文 | 7563篇 |
免费 | 2568篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 222篇 |
儿科学 | 263篇 |
妇产科学 | 210篇 |
基础医学 | 244篇 |
口腔科学 | 52篇 |
临床医学 | 1191篇 |
内科学 | 2156篇 |
皮肤病学 | 432篇 |
神经病学 | 700篇 |
特种医学 | 194篇 |
外科学 | 2325篇 |
综合类 | 49篇 |
一般理论 | 1篇 |
预防医学 | 679篇 |
眼科学 | 613篇 |
药学 | 136篇 |
中国医学 | 2篇 |
肿瘤学 | 695篇 |
出版年
2024年 | 89篇 |
2023年 | 718篇 |
2022年 | 131篇 |
2021年 | 342篇 |
2020年 | 403篇 |
2019年 | 173篇 |
2018年 | 675篇 |
2017年 | 742篇 |
2016年 | 656篇 |
2015年 | 601篇 |
2014年 | 799篇 |
2013年 | 714篇 |
2012年 | 369篇 |
2011年 | 335篇 |
2010年 | 512篇 |
2009年 | 678篇 |
2008年 | 301篇 |
2007年 | 171篇 |
2006年 | 228篇 |
2005年 | 139篇 |
2004年 | 99篇 |
2003年 | 77篇 |
2002年 | 86篇 |
2001年 | 127篇 |
2000年 | 64篇 |
1999年 | 100篇 |
1998年 | 98篇 |
1997年 | 97篇 |
1996年 | 70篇 |
1995年 | 70篇 |
1994年 | 46篇 |
1993年 | 35篇 |
1992年 | 50篇 |
1991年 | 46篇 |
1990年 | 44篇 |
1989年 | 32篇 |
1988年 | 33篇 |
1987年 | 20篇 |
1986年 | 21篇 |
1985年 | 15篇 |
1983年 | 15篇 |
1982年 | 15篇 |
1981年 | 9篇 |
1980年 | 11篇 |
1979年 | 13篇 |
1978年 | 11篇 |
1976年 | 8篇 |
1973年 | 9篇 |
1971年 | 6篇 |
1961年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
Ashok K. Saxena MD DA FAMS Namita Nasare MPharm Smita Jain MSc Gaurav Dhakate MBBS DNB Rafat S. Ahmed PhD Sambit N. Bhattacharya MD Pramod K. Mediratta MD Basu D. Banerjee MPhil PhD 《Pain practice》2013,13(4):264-275
Objective: To evaluate the safety and efficacy of oral tramadol therapy (50 to 200 mg/day) in the treatment for post‐herpetic neuralgia (PHN). Methods: The study was a prospective, single‐blind, non‐responder vs. responder, randomized trial conducted in 100 outpatients of PHN after oral administration of tramadol for 4 weeks. Those patients who had achieved 50% or greater pain relief after 14 days of oral tramadol treatment were categorized as responders and those reporting < 50% pain relief were categorized as non‐responders. Rescue analgesia was provided by the topical application of a cream consisting of the combination of 3.33% doxepin and 0.05% capsaicin to the affected areas of PHN patients of both groups for at least 14 days, along with tramadol therapy. The rescue analgesia was extended to 4 weeks in patients of the non‐responder group. The primary endpoints were measured using a Numerical Rating Scale (NRS) at rest and with movement. Secondary endpoints included additional pain ratings such as global perceived effect (GPE), Neuropathic Pain Symptom Inventory scores (NPSI), daily sleep interference score (DSIS), Quality of life (QOL) as per WHO QOL‐BREF Questionnaire scores, patient and clinician ratings of global improvement. The 2 groups were compared on the basis of pain intensity scores, encompassing primary as well as secondary endpoints, and QOL after 28 days of the treatment regimen. Results: Pain intensity scores measured by NRS (at resting and with movement), NPSI, and DSIS were consistently reduced (P < 0.001) over 28 days at varying intervals in both the groups, but the magnitude of reduction was higher in responders than non‐responders. A concomitant improvement (P < 0.001) was observed in GPE on days 3, 14, and 28 as compared to the respective baseline scores in both the groups. Although the WHO QOL‐BREF scores showed significant (P < 0.001) improvement in QOL of PHN patients at days 14 and 28 in both the groups, the magnitude of improvement was higher in responders as compared to non‐responders. Significant improvement in pain intensity scores and QOL in non‐responders is mainly attributed to the use of rescue analgesia for 28 days rather than recommended tramadol therapy. Conclusions: Treatment with tramadol 50 to 200 mg per day was associated with significant pain reduction in terms of enhanced pain relief, reduced sleep interference, greater global improvement, diminished side‐effect profile, and improved QOL in PHN patients from North India. Further categorization of PHN patients may be helpful so that additional or alternative therapy may be prescribed to non‐responders. 相似文献
993.
994.
Job satisfaction and resilience in psychiatric nurses: A study at the Institute of Mental Health,Singapore 下载免费PDF全文
Zhimin Zheng MBBS MRCPsych Poornima Gangaram MBBS MRCPsych Huiting Xie PhD RN RMN Stephanie Chua BPsych Samantha Bee Cheng Ong EMBA Sioh Eng Koh MHA 《International journal of mental health nursing》2017,26(6):612-619
Job satisfaction ranks highly as one of the main factors influencing turnover rates among nurses. Mental health nursing has been reported to be a particularly stressful specialty, yet little is known about the level of job satisfaction among psychiatric nurses in Singapore. Resilience is defined as a means of adapting to stress at the workplace, and could serve as a factor influencing job satisfaction. The present study aimed to explore the current level of job satisfaction among psychiatric nurses working in the only tertiary psychiatric institution in Singapore, the influencing factors, and the relationship between resilience and job satisfaction. A survey questionnaire consisting of the following was administered to all eligible nurses working in the Institute of Mental Health between the period of 16–24 December 2014: (i) The McCloskey and Mueller Satisfaction Scale; (ii) The Resilience Scale; and (iii) sociodemographic data form. A total of 874 nurses were eligible for participation in the study, and a total of 748 nurses responded, totalling 85.6% response. A mean satisfaction score of 95.21 and mean resilience score of 125.74 were obtained. Mean satisfaction and resilience scores were the highest for nurses with longer working experience and those of older age. A positive and significant association between satisfaction and resilience scores (P = 0.001) was obtained. Psychiatric nurses in Singapore are generally satisfied with their job, but this can be further improved with the strengthening of personal resilience. 相似文献
995.
996.
Adam Lee MBBS MMed Heidi Kohler BNurs Daniel Wright BAppSci Haris M. Haqqani MBBS PhD FHRS 《Pacing and clinical electrophysiology : PACE》2017,40(11):1308-1312
Patients with Brugada syndrome are at risk of life‐threatening ventricular arrhythmias. Epicardial substrate ablation for Brugada syndrome has been described as a means of controlling these arrhythmias and recent reports describe elimination of the Brugada phenotype with ablation. We describe a unique case in which a patient developed inferior J waves with an early repolarization‐type electrocardiogram following successful epicardial infundibular substrate ablation (which eliminated the Brugada syndrome electrocardiogram on ajmaline challenge). We discuss the likely underlying pathophysiology responsible for this phenomenon, its relationship to the anatomic obstacles encountered during epicardial ablation, and the implications for long‐term arrhythmic risk. 相似文献
997.
Lifetime Risk of Primary Total Hip Replacement Surgery for Osteoarthritis From 2003 to 2013: A Multinational Analysis Using National Registry Data 下载免费PDF全文
Ilana N. Ackerman PhD Megan A. Bohensky PhD Richard de Steiger MBBS Caroline A. Brand MPH Antti Eskelinen MD Anne Marie Fenstad MSc Ove Furnes PhD Stephen E. Graves DPhil Jaason Haapakoski MSc Keijo Mäkelä PhD Frank Mehnert MSc Szilard Nemes PhD Søren Overgaard MD Alma B. Pedersen PhD Göran Garellick PhD 《Arthritis care & research》2017,69(11):1659-1667
Objective
To compare the lifetime risk of total hip replacement (THR ) surgery for osteoarthritis (OA ) between countries, and over time.Methods
Data on primary THR procedures performed for OA in 2003 and 2013 were extracted from national arthroplasty registries in Australia, Denmark, Finland, Norway, and Sweden. Life tables and population data were also obtained for each country. Lifetime risk of THR was calculated for 2003 and 2013 using registry, life table, and population data.Results
In 2003, lifetime risk of THR ranged from 8.7% (Denmark) to 15.9% (Norway) for females, and from 6.3% (Denmark) to 8.6% (Finland) for males. With the exception of females in Norway (where lifetime risk started and remained high), lifetime risk of THR increased significantly for both sexes in all countries from 2003 to 2013. In 2013, lifetime risk of THR was as high as 1 in 7 women in Norway, and 1 in 10 men in Finland. Females consistently demonstrated the highest lifetime risk of THR at both time points. Notably, lifetime risk for females in Norway was approximately double the risk for males in 2003 (females 15.9% [95% confidence interval (95% CI ) 15.6–16.1], males 6.9% [95% CI 6.7–7.1]), and 2013 (females 16.0% [95% CI 15.8–16.3], males 8.3% [95% CI 8.1–8.5]).Conclusion
Using representative, population‐based data, this study found statistically significant increases in the lifetime risk of THR in 5 countries over a 10‐year period, and substantial between‐sex differences. These multinational risk estimates can inform resource planning for OA service delivery.998.
Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus™ transcatheter aortic valve 下载免费PDF全文
999.
A case of bronchopericardial fistula with tension pneumopericardium closed successfully by transpericardial intervention: A novel procedure 下载免费PDF全文
Abhijeet B. Shelke MD DNB Ramesh Kawade MBBS PGDCC Sourabh Gandhi MD 《Catheterization and cardiovascular interventions》2017,90(7):1117-1120
A pneumopericardium is a collection of air or gas in the pericardial sac which may cause cardiac tamponade, known as tension pneumopericardium. Tension pneumopericardium is a rare and lethal presentation of bronchopericardial fistula. There are very few reports in the literature of patients surviving with this condition, although prompt diagnosis and early intervention are important. Treatment options are limited. We present a rare case of tension pneumopericardium with cardiogenic shock due to bronchopericardial fistula in a patient with bronchogenic carcinoma who was successfully treated with transpericardial intervention. 相似文献
1000.